Ningfei An

641 total citations
24 papers, 510 citations indexed

About

Ningfei An is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Ningfei An has authored 24 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Hematology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Ningfei An's work include Cancer Mechanisms and Therapy (7 papers), Multiple Myeloma Research and Treatments (5 papers) and Acute Myeloid Leukemia Research (3 papers). Ningfei An is often cited by papers focused on Cancer Mechanisms and Therapy (7 papers), Multiple Myeloma Research and Treatments (5 papers) and Acute Myeloid Leukemia Research (3 papers). Ningfei An collaborates with scholars based in United States, Canada and China. Ningfei An's co-authors include Yubin Kang, Andrew S. Kraft, Jin H. Song, J Blumer, Stephen M. Lanier, Saira Khan, Megan E. McNerney, Houjian Cai, Ali Vural and Şükrü Sadik Öner and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Ningfei An

22 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ningfei An United States 15 342 135 116 113 59 24 510
Ying-Wei Lin United States 9 340 1.0× 236 1.7× 202 1.7× 93 0.8× 111 1.9× 9 557
Scott Ackler United States 8 472 1.4× 94 0.7× 233 2.0× 38 0.3× 75 1.3× 10 625
Shengyan Xiang United States 16 765 2.2× 61 0.5× 273 2.4× 134 1.2× 58 1.0× 25 919
Sho Kubota Japan 16 369 1.1× 30 0.2× 122 1.1× 97 0.9× 65 1.1× 46 552
Andrew Capen United States 9 511 1.5× 103 0.8× 212 1.8× 30 0.3× 42 0.7× 19 724
Joshua J. Oaks United States 9 710 2.1× 41 0.3× 115 1.0× 169 1.5× 90 1.5× 19 876
Susan Jones‐Bolin United States 9 424 1.2× 52 0.4× 184 1.6× 339 3.0× 41 0.7× 14 769
Ying-Yi Li China 13 344 1.0× 190 1.4× 263 2.3× 28 0.2× 68 1.2× 30 624
Meejeon Roh United States 14 407 1.2× 145 1.1× 254 2.2× 29 0.3× 111 1.9× 21 740
Jessica Oddo United States 6 457 1.3× 35 0.3× 138 1.2× 60 0.5× 32 0.5× 10 558

Countries citing papers authored by Ningfei An

Since Specialization
Citations

This map shows the geographic impact of Ningfei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningfei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningfei An more than expected).

Fields of papers citing papers by Ningfei An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningfei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningfei An. The network helps show where Ningfei An may publish in the future.

Co-authorship network of co-authors of Ningfei An

This figure shows the co-authorship network connecting the top 25 collaborators of Ningfei An. A scholar is included among the top collaborators of Ningfei An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningfei An. Ningfei An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stoddart, Angela, John H. M. Austin, Ningfei An, et al.. (2025). Multiplex gene editing models of del(7q) reveal combined CUX1 and EZH2 loss drives clonal expansion and drug resistance. PubMed. 2(2). 100083–100083.
2.
An, Ningfei, et al.. (2023). Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells. Oncogene. 42(12). 881–893. 4 indexed citations
3.
An, Ningfei, Saira Khan, Donald J. Wolfgeher, et al.. (2021). Loss of a 7q gene,CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms. Blood. 138(9). 790–805. 16 indexed citations
5.
An, Ningfei, Bo Cen, Houjian Cai, et al.. (2016). Pim1 kinase regulates c-Kit gene translation. Experimental Hematology and Oncology. 5(1). 31–31. 14 indexed citations
6.
An, Ningfei, Ying Xiong, Amanda C. LaRue, Andrew S. Kraft, & Bo Cen. (2015). Activation of Pim Kinases Is Sufficient to Promote Resistance to MET Small-Molecule Inhibitors. Cancer Research. 75(24). 5318–5328. 21 indexed citations
7.
An, Ningfei, Robert K. Stuart, Luciano J. Costa, et al.. (2014). Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma. Blood. 124(12). 1915–1925. 93 indexed citations
8.
Song, Jin H., Ningfei An, Shilpak Chatterjee, et al.. (2014). Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing. Oncogene. 34(28). 3728–3736. 32 indexed citations
9.
An, Ningfei & Yubin Kang. (2014). Thioredoxin and Hematologic Malignancies. Advances in cancer research. 122. 245–279. 17 indexed citations
10.
An, Ningfei, Michael G. Janech, Alison M. Bland, et al.. (2013). Proteomic analysis of murine bone marrow niche microenvironment identifies thioredoxin as a novel agent for radioprotection and for enhancing donor cell reconstitution. Experimental Hematology. 41(11). 944–956. 7 indexed citations
11.
An, Ningfei & Yubin Kang. (2013). Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model. Journal of Visualized Experiments. e50193–e50193. 21 indexed citations
12.
An, Ningfei & Yubin Kang. (2013). In vivo BrdU Incorporation Assay for Murine Hematopioetic Stem Cells. BIO-PROTOCOL. 3(21). 3 indexed citations
13.
An, Ningfei, Andrew S. Kraft, & Yubin Kang. (2013). Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice. Journal of Hematology & Oncology. 6(1). 12–12. 36 indexed citations
14.
An, Ningfei & Yubin Kang. (2013). Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model. Journal of Visualized Experiments. 7 indexed citations
15.
Wu, Lixian, Ningfei An, Junru Wang, et al.. (2011). IKKβ Regulates the Repair of DNA Double-Strand Breaks Induced by Ionizing Radiation in MCF-7 Breast Cancer Cells. PLoS ONE. 6(4). e18447–e18447. 28 indexed citations
16.
Öner, Şükrü Sadik, Ningfei An, Ali Vural, et al.. (2010). Regulation of the AGS3·Gαi Signaling Complex by a Seven-transmembrane Span Receptor*. Journal of Biological Chemistry. 285(44). 33949–33958. 40 indexed citations
18.
Pazhanisamy, Senthil, Ningfei An, Yong Wang, & Daohong Zhou. (2009). Hematopoietic Stem Cells Repair Ionizing Radiation-Induced DNA Double Strand Breaks in a Cell Cycle-Dependent Manner.. Blood. 114(22). 3241–3241.
19.
An, Ningfei, J Blumer, Michael L. Bernard, & Stephen M. Lanier. (2008). The PDZ and Band 4.1 Containing Protein Frmpd1 Regulates the Subcellular Location of Activator of G-protein Signaling 3 and Its Interaction with G-proteins. Journal of Biological Chemistry. 283(36). 24718–24728. 26 indexed citations
20.
Kuang, Rong, et al.. (2001). The anti-inflammatory effects of the n-butanol extract of Xanthoceras sorbifolia Bunge. Europe PMC (PubMed Central). 18(1). 53–56. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026